Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

MC1742

🥰Excellent
Catalog No. T35762Cas No. 1776116-74-5
Alias MC 1742

MC1742 is a broad-spectrum HDAC inhibitor, inhibiting HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10, and HDAC11. MC1742 inhibits the growth of parasites in vitro, blocking the growth of Toxoplasma gondii tachyzoites and severely disrupting the expression of parasitic genes. MC1742 has potential anticancer activity, inhibiting the growth arrest, apoptosis, and growth of cancer cells. MC1742 has potential anticancer activity, inhibiting growth arrest, apoptosis and differentiation of cancer cells.

MC1742

MC1742

🥰Excellent
Purity: 99.20%
Catalog No. T35762Alias MC 1742Cas No. 1776116-74-5
MC1742 is a broad-spectrum HDAC inhibitor, inhibiting HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10, and HDAC11. MC1742 inhibits the growth of parasites in vitro, blocking the growth of Toxoplasma gondii tachyzoites and severely disrupting the expression of parasitic genes. MC1742 has potential anticancer activity, inhibiting the growth arrest, apoptosis, and growth of cancer cells. MC1742 has potential anticancer activity, inhibiting growth arrest, apoptosis and differentiation of cancer cells.
Pack SizePriceAvailabilityQuantity
2 mg$100In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:99.20%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
MC1742 is a broad-spectrum HDAC inhibitor, inhibiting HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10, and HDAC11. MC1742 inhibits the growth of parasites in vitro, blocking the growth of Toxoplasma gondii tachyzoites and severely disrupting the expression of parasitic genes. MC1742 has potential anticancer activity, inhibiting the growth arrest, apoptosis, and growth of cancer cells. MC1742 has potential anticancer activity, inhibiting growth arrest, apoptosis and differentiation of cancer cells.
Targets&IC50
HDAC1:0.1 μM, HDAC2:0.11 μM, HDAC11:0.1 μM, HDAC3:0.02 μM, HDAC10:0.04 μM, HDAC8:0.61 μM, HDAC6:0.007 μM
In vitro
MC1742 is a potent HDAC inhibitor with IC50 values of 0.1 μM, 0.11 μM, 0.02 μM, 0.007 μM, 0.61 μM, 0.04 μM, and 0.1 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10, and HDAC11, respectively.MC1742 was able to increase the levels of acetylated-H3 and acetylated microtubule proteins and inhibit the proliferation of cancer stem cells.
MC1742 (0.5 and 2 μM; 24 h) was able to enhance acetylation levels in a dose-dependent manner, as evidenced by patchy nuclear staining of acetylated histone H3.
MC1742 (0.5, 1 and 2 μM; 24, 48 and 72 h) significantly induced apoptosis in all cancer stem cell cultures.
MC1742 (0.025-0.5 μM; 14 days) was able to significantly promote bone vesicle formation with a dose-dependent effect. [1]
AliasMC 1742
Chemical Properties
Molecular Weight395.48
FormulaC21H21N3O3S
Cas No.1776116-74-5
SmilesO=C1N=C(SCCCCC(=O)NO)NC(=C1)C=2C=CC(=CC2)C=3C=CC=CC3
Relative Density.1.29 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 160.00 mg/mL (404.57 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5286 mL12.6429 mL25.2857 mL126.4286 mL
5 mM0.5057 mL2.5286 mL5.0571 mL25.2857 mL
10 mM0.2529 mL1.2643 mL2.5286 mL12.6429 mL
20 mM0.1264 mL0.6321 mL1.2643 mL6.3214 mL
50 mM0.0506 mL0.2529 mL0.5057 mL2.5286 mL
100 mM0.0253 mL0.1264 mL0.2529 mL1.2643 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy MC1742 | purchase MC1742 | MC1742 cost | order MC1742 | MC1742 chemical structure | MC1742 in vitro | MC1742 formula | MC1742 molecular weight